logo
  

Commercial Metals Q3 Profit Rises - Quick Facts

Steel and metal products maker Commercial Metals Co. (CMC) said its third-quarter net earnings attributable to the company was $56.7 million, or $0.49 per share, up from $23.6 million, or $0.20 per share in the comparable quarter last year. On average, 10 analysts polled by Thomson Reuters expected the company to report profit per share of $0.39 for the quarter. Analysts' estimates typically exclude special items.

Earnings from continuing operations for the latest third quarter were $67.1 million or $0.58 per share, compared with $24.5 million or $0.21 per share in the prior year.

Results for the recent period included after-tax LIFO income from continuing operations of $24.1 million, or $0.21 per share, compared with an after-tax LIFO expense from continuing operations of $5.3 million, or $0.04 per share, for the third quarter of fiscal 2014, the company said.

Quarterly net sales were $1.51 billion, down from the prior-year figure of $1.74 billion. Analysts anticipated revenue of $1.58 billion for the quarter.

On June 24, 2015, the board of directors of CMC declared a quarterly dividend of $0.12 per share for shareholders of record on July 9, 2015.  The dividend will be paid on July 23, 2015.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
While reporting financial results for the first quarter on Wednesday, medical devices company Boston Scientific Corp. (BSX) raised its adjusted earnings and net sales growth guidance for the full-year 2024. For fiscal 2024, the company now projects earnings in a range of $1.43 to $1.48 per share and... Shares of Roche Holding AG were losing around 3 percent in Switzerland after the drug major reported weak sales in its first quarter and confirmed fiscal 2024 outlook. Excluding COVID-19-related products, quarterly sales increasedy 7 percent. For fiscal 2024, Roche continues to expect an increase in group sales in the mid single digit range at constant exchange rates. Dr. Reddy's Laboratories Ltd. is recalling six lots of Sapropterin Dihydrochloride Powder for Oral Solution 100 mg to the consumer level. According to the U.S. Food and Drug Administration, the recall was due to powder discoloration in some packets leading to decreased potency.

This week, we feature Nigeria’s combat with meningitis, Hostile takeover bid for Vanda Pharma, US opioid crisis, Sammy’s Milk’s safety concerns, and X4’s Mavorixafor’s fast-track status.

View More Videos
RELATED NEWS
Follow RTT